Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by Claridgeon Dec 13, 2019 8:50pm
210 Views
Post# 30454202

CapWealth, our first institutional investor ... and a US one

CapWealth, our first institutional investor ... and a US oneOur first institutional investor, a private one, and one from the US ...

Not much, spare change in fact for them, but this is a start.  At least, our first institutional.  Would be interesting to learn though how they heard about us.

We'll if they add more on key milestones (IND, 3-month interim data, etc ...) and if others step in too. 

Located in Tennessee

With over $1 billion in client assets under management
, we are one of the nation's leading independent wealth managers, and as a privately owned, independently managed firm, CapWealth's team has a personal stake in the success of our clients.


In 2018, CapWealth Chairman and Chief Investment Officer Tim Pagliara was named No. 1 Financial Advisor in Tennessee by Barron’s at the same time as being named No. 1 Wealth Manager in Tennessee by Forbes.

Tim had previously been named to the top spot by Barron's multiple times, but this was the first time any advisor has been named No. 1 by both publications at the same time.


In 2014, the Financial Times named CapWealth one of the Top 300 Registered Investment Advisory Firms and President and Chief Executive Officer Phoebe Venable one of the Top 100 Women Financial Advisors in the country.


1 Institutional Holders
103,000 Total Shares Held
OWNER NAME DATE SHARES HELD CHANGE (SHARES) CHANGE (%) VALUE (IN 1,000S)
CAPWEALT H ADVISORS, LLC 09/30/2019 103,000 0 0% $24

Bullboard Posts